- Lobbying
- Lobbying by Roche Diagnostics Corporation, Inc.
Lobbying Relationship
Lobbyists
Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.
Lobbyist | Covered positions? |
---|---|
Andrea Bergman | 1999-2001: Legislative Assistant, Sen. Michael Crapo; 1996-98: Legislative Assistant, Rep. Michael Crapo |
Sheila Walcoff | 2006-07: Counselor to The Honorable Michael O. Leavitt (Immediate Office of the Secretary), U.S. Dept of Health/Human Services; 2004-06: Assoc Commissioner for External Relations, U.S. FDA; 1998-99: Majority Counsel, Armed Services Committee, U.S. House of Representatives |
Eric Zimmerman | n/a |
Paul Radensky MD | n/a |
Paul Radensky | n/a |
Disclosures Filed
Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.
Termination
Q2 Report
Q1 Report
Q4 Report
Q3 Report
Q2 Report
Q1 Report
Q4 Report
Q3 Report
Q2 Report
Q1 Report
Q4 Report
Q3 Report
Q2 Report
Amendment
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Q1 Report
Lobbying Issues
Agencies Lobbied
U.S. Senate
Type of Issue
Q4 Report
Q3 Report
Q2 Report
Lobbying Issues
Agencies Lobbied
U.S. Senate
Type of Issue
Q1 Report
Q4 Report
Q3 Report
Q2 Report
Q1 Report
Lobbying Issues
Agencies Lobbied
U.S. Senate
Type of Issue
Lobbying Issues
Agencies Lobbied
U.S. Senate
Type of Issue
Q4 Report
Lobbying Issues
Agencies Lobbied
U.S. Senate
Type of Issue
Lobbying Issues
Agencies Lobbied
U.S. Senate
Type of Issue
Q3 Report
Q2 Report
Lobbying Issues
Agencies Lobbied
U.S. Senate,
Type of Issue
Q1 Report
Lobbying Issues
Agencies Lobbied
U.S. Senate
Food & Drug Administration (FDA)
Type of Issue
Lobbying Issues
Agencies Lobbied
U.S. Senate
Type of Issue
Q4 Report
Lobbying Issues
Agencies Lobbied
U.S. Senate
Food & Drug Administration (FDA)
Type of Issue
Q3 Report
Lobbying Issues
Agencies Lobbied
U.S. Senate
Food & Drug Administration (FDA)
Type of Issue
Q2 Report
Lobbying Issues
Agencies Lobbied
U.S. Senate
Food & Drug Administration (FDA)
Type of Issue
Q1 Report
Q4 Report
Q3 Report
Q2 Report
Q1 Report
Q4 Report
Lobbying Issues
Agencies Lobbied
U.S. Senate
Centers For Medicare and Medicaid Services (CMS)
Health & Human Services - Dept of (HHS)
Type of Issue
Q3 Report
Lobbying Issues
Agencies Lobbied
U.S. Senate
Centers For Medicare and Medicaid Services (CMS)
Health & Human Services - Dept of (HHS)
Type of Issue
Registration
Issue(s) they said they’d lobby about: Medicare coverage and reimbursement for home monitoring of anticoagulation management.
Source: Clerk of the U.S. House of Representatives and Secretary of the Senate